HARVARD BIOSCIENCE INC — Director's Dealing 2021

Nov 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2021-11-01

Reporting Person: Olson Kenneth Fletcher (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-01	Common Stock	F	1539	$7.37	Disposed	161754	Direct

Footnotes

F1: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with the performance restricted stock unit award previously granted to the Reporting Person that vested in part on November 1, 2021.

F2: Includes (a) 36,756 remaining restricted stock units that will vest on June 11, 2022 and 2023, (b) 32,805 restricted stock units that will vest in three equal installments on December 31, 2021, 2022 and 2023, (c) 31,453 restricted stock units with performance based vesting conditions, (d) 27,567 remaining restricted stock units that will vest on December 31, 2021, 2022 and 2023, (e) 5,029 remaining restricted stock units that will vest on November 1, 2022, and (f) 28,144 shares of common stock beneficially owned by the Reporting Person (which includes 3,644 shares acquired under the Issuer's Employee Stock Purchase Plan).